2 research outputs found

    image_2.tiff

    No full text
    Objective<p>Autoimmune lymphoproliferative syndrome (ALPS) with FAS mutation (ALPS-FAS) is a nonmalignant, noninfectious, lymphoproliferative disease with autoimmunity. Given the central role of natural regulatory T cells (nTregs) in the control of lymphoproliferation and autoimmunity, we assessed nTreg-suppressive function in 16 patients with ALPS-FAS.</p>Results<p>The proportion of CD25<sup>high</sup>CD127<sup>low</sup> Tregs was lower in ALPS-FAS patients than in healthy controls. This subset was correlated with a reduced CD25 expression in CD3<sup>+</sup>CD4<sup>+</sup> T cells from ALPS patients and thus an abnormally low proportion of CD25<sup>high</sup>FOXP3<sup>+</sup> Helios<sup>+</sup> T cells. The ALPS patients also displayed a high proportion of naïve Treg (FOXP3<sup>low</sup>CD45RA<sup>+</sup>) and an unusual subpopulation (CD4<sup>+</sup>CD127<sup>low</sup>CD15s<sup>+</sup>CD45RA<sup>+</sup>). Despite this abnormal phenotype, the CD25<sup>high</sup>CD127<sup>low</sup> Tregs’ suppressive function was unaffected. Furthermore, conventional T cells from FAS-mutated patients showed normal levels of sensitivity to Treg suppression.</p>Conclusion<p>An abnormal Treg phenotype is observed in circulating lymphocytes of ALPS patients. However, these Tregs displayed a normal suppressive function on T effector proliferation in vitro. This is suggesting that lymphoproliferation observed in ALPS patients does not result from Tregs functional defect or T effector cells insensitivity to Tregs suppression.</p

    image_1.tiff

    No full text
    Objective<p>Autoimmune lymphoproliferative syndrome (ALPS) with FAS mutation (ALPS-FAS) is a nonmalignant, noninfectious, lymphoproliferative disease with autoimmunity. Given the central role of natural regulatory T cells (nTregs) in the control of lymphoproliferation and autoimmunity, we assessed nTreg-suppressive function in 16 patients with ALPS-FAS.</p>Results<p>The proportion of CD25<sup>high</sup>CD127<sup>low</sup> Tregs was lower in ALPS-FAS patients than in healthy controls. This subset was correlated with a reduced CD25 expression in CD3<sup>+</sup>CD4<sup>+</sup> T cells from ALPS patients and thus an abnormally low proportion of CD25<sup>high</sup>FOXP3<sup>+</sup> Helios<sup>+</sup> T cells. The ALPS patients also displayed a high proportion of naïve Treg (FOXP3<sup>low</sup>CD45RA<sup>+</sup>) and an unusual subpopulation (CD4<sup>+</sup>CD127<sup>low</sup>CD15s<sup>+</sup>CD45RA<sup>+</sup>). Despite this abnormal phenotype, the CD25<sup>high</sup>CD127<sup>low</sup> Tregs’ suppressive function was unaffected. Furthermore, conventional T cells from FAS-mutated patients showed normal levels of sensitivity to Treg suppression.</p>Conclusion<p>An abnormal Treg phenotype is observed in circulating lymphocytes of ALPS patients. However, these Tregs displayed a normal suppressive function on T effector proliferation in vitro. This is suggesting that lymphoproliferation observed in ALPS patients does not result from Tregs functional defect or T effector cells insensitivity to Tregs suppression.</p
    corecore